Bioresearch Monitoring (BIMO) Fiscal Year 2019 Metrics

On 8 April 2020 the FDA published the bioresearch monitoring inspection metrics for the fiscal year 2019.

The inspectional data cover all aspects of FDA’s BIMO program (i.e., clinical investigators, IRBs, sponsors, bioequivalence, and good laboratory practices) for all Centers, as applicable. These data were provided by the individual Centers and may differ from other inspection data available on FDA’s website, as different criteria and/or methods for compiling the information may have been used.

Read more online 
Copyright Widler & Schiemann AG 2020. All Rights Reserved. /